Specialty
Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Market Access Challenges in Retinal Disease

Identifying and Addressing Market Access Challenges with Anti VEGF Therapies for Patients with Retinal Disease - Supplement

View Course

Maintaining Access to Anti-VEGF Agents in Retinal Disease

View Course

Shared Decision Making in Retinal Disease Management

View Course

MACRA, MIPS and DQSA: Unpacking the Acronyms and What They Mean for Ophthalmologists

View Course

How to Combat Challenges Faced in Obtaining Access to Approved Anti-VEGF Medications

View Course

Your Balance Sheet in Q1-2019: A Focus on Step Therapy for Retinal Disease

View Course

Identifying and Addressing Market Access Challenges with Anti VEGF Therapies for Patients with Retinal Disease - Supplement

View Course

Maintaining Access to Anti-VEGF Agents in Retinal Disease

View Course

Shared Decision Making in Retinal Disease Management

View Course

MACRA, MIPS and DQSA: Unpacking the Acronyms and What They Mean for Ophthalmologists

View Course

How to Combat Challenges Faced in Obtaining Access to Approved Anti-VEGF Medications

View Course

Your Balance Sheet in Q1-2019: A Focus on Step Therapy for Retinal Disease

View Course

Introduction

Welcome, from David Eichenbaum, MD

David Eichenbaum, MD

Courses

IDENTIFYING AND ADDRESSING MARKET ACCESS CHALLENGES WITH ANTI-VEGF THERAPIES FOR PATIENTS WITH RETINAL DISEASE
Supplement Credits: 1.0
View Course
Maintaining Access to Anti-VEGF Agents in Retinal Disease

Multimedia Activity
Credits: 0.5
Login Required
Shared Decision Making in Retinal Disease Management

Multimedia Activity
Credits: 0.5
Login Required
MACRA, MIPS and DQSA: Unpacking the Acronyms and What They Mean for Ophthalmologists

Multimedia Activity
Credits: 0.5
Login Required
How to Combat Challenges Faced in Obtaining Access to Approved Anti-VEGF Medications
Supplement Credits: 1
View Course
Your Balance Sheet in Q1-2019: A Focus on Step Therapy for Retinal Disease

Webinar

Multimedia Activity
Credits: .75
Login Required

Register

What’s Changing in 2019: Market Access Challenges with Anti-VEGF Therapies

Four Seasons - Dallas, Texas • March 30, 2019 630pm-830pm

Register
Navigating the Payer Maze: Setting Your Practice Up for Success

Webinar • April 1, 2019 830pm EST

Register